CRYOSITE LIMITED

ASX:CTEPharmaceuticals, Biotechnology & Life Sciences

48.8M shares on issueASX (delayed) · snapshot 11 Sept 202651.5M fully diluted+5.5% if every option and right converts$1.18price · delayed$57.6Mmarket cap · indicative

Today’s holders own 94.8% of what they think they own, once every option and right converts.

Minimal

Dilution risk

Options/rights overhang 6% of shares

Absolute levels — not a ranking against other companies.

Cash runwayno data — not a quarterly (4C/5B) cash filer

Share-count growth (24m)0.0%no issuance filings since 2024

Raise cadence (24m)0 cash raises

Options & rights overhang5.5% of shares

In-the-money supplyno data — no exercise price on record

Pending proposed issuesnone

CRYOSITE LIMITED has no ordinary share count change filings on record since January 2024. The company has not raised capital in the past 24 months and has no pending proposed securities issues. Options on issue could convert into 3M new shares, representing 5.5% of the current share count; none are currently in the money, and no filing states an expiry date for these securities. There is no current quarterly cash report on record, so no cash balance or funding runway is disclosed.

AI-generated summary of this page's cited filings · updated 1 Sept 2026

Get told when this changes

Set up alerts

Daily email alerts cover risk-level moves, new raises, pending proposed issues and option expiries for the companies you follow.

5.5%

Options & rights overhang

—

In-the-money supply · no stated strikes

Raises · last 12 months

—

Cash cover · not a quarterly filer

Shares on issue — last 2 years

Ordinary shares on issue

Weekly counts from ASX records. Dots mark cash capital raises. Latest count 48.8M per ASX (delayed) (snapshot 11 Sept 2026).

Cash runway

Not a quarterly cash filer. This company does not lodge Appendix 4C/5B quarterly cash reports, so cash runway does not apply.

Issuance timeline

Latest 3 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

Date	Form	Security	On issue, per this filing	Source
18 Mar 2026	3G · unquoted	ORDINARY FULLY PAID	48.8M	Appendix 3G
23 Oct 2025	3G · unquoted	CTE : ORDINARY FULLY PAID	48.8M	Appendix 3G
17 Mar 2025	3G · unquoted	CTE : ORDINARY FULLY PAID	48.8M	Appendix 3G

Free account

3 filings on record — Full issuance history

Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).

Free account: 2 full company unlocks every month, no card.

Create free account See plans

Capital raises

No equity raises in the last 24 months.

Free account

Full raise history

Issue price, shares issued, brokers and stated purpose for every raise on record.

Free account: 2 full company unlocks every month, no card.

Create free account See plans

Forward supply

Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.

Free account

Forward supply calendar

Option expiries and proposed issues on one forward timeline, with the securities each could add.

Free account: 2 full company unlocks every month, no card.

Create free account See plans

Placement capacity

How much stock a company can place without asking holders. Listing Rule 7.1 allows 15% of ordinary securities in any 12 months, and every Appendix 3B states how much of it an issue uses.

No Appendix 3B in the last 12 months reports an issue under the 15% placement capacity (as at 2026-09-12).

Free account

Placement capacity — LR 7.1 / 7.1A

The filings behind the figure: every Appendix 3B in the window with what it says was issued under 7.1 and 7.1A, each row linked to its filing, and how many shares are left.

Free account: 2 full company unlocks every month, no card.

Create free account See plans

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

5.5%

Options & rights overhang · of current shares

—

In-the-money supply · no stated strikes

2.7M

Potential new shares

—

Nearest expiry

What a price move would switch on

No option supply on record carries an exercise price to pay, so no share price switches any of it on. All 2.7M of it converts on something else — a hurdle that may never be met, or terms the filing does not price.

Code	Security	Type	Exercise price	Expiry	On issue	Source
CTEAC	Options	Price-triggered	—	—	2.7M	Filing

“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column.

Free account

1 option line on record — In-the-money value & price ladder

What each line is worth in the money today, the price ladder to the next tranche that converts, and the filing description behind every code.

Free account: 2 full company unlocks every month, no card.

Create free account See plans